According to data presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, atrial fibrillation (Afib) is more common in women with breast cancer compared to other women of the same age, and Afib is associated with worse outcomes from breast cancer. “A better understanding of the clinical outcomes in women with breast cancer and Afib can help stratify patients’ risk and inform clinical decision-making,” wrote the authors, led by Mohamed M. Gad, of the Cleveland Clinic Foundation in Ohio. Specifically, they added, “Stratifying patients based on Afib presence can help inform clinicians ...
ASCO 2022: Focus on Breast Cancer
Advertisement
Triple-negative breast cancer tends to have relatively poor long-term outcomes compared to other subtypes of breast cancer.
Research has shown that women with breast cancer who live in socioeconomically disadvantaged areas have poorer outcomes.
The study noted differences between patients according to risk status.
Younger patients with breast cancer tend to have a poorer prognosis and higher rates of recurrence.
The new data is being used to develop a biomarker tool to predict the efficacy of neoadjuvant pembrolizumab.
“CTCs contribute to the metastatic cascade and represent an independent survival predictor in breast cancer."
Advertisement
